Improved synthesis strategy for peptide nucleic acids (PNA) appropriate for cell-specific fluorescence imaging

Area of Science:

• Biomedical research
• Metabolomics
• Molecular imaging

Background:

• Advancements in genomics and proteomics are crucial for understanding complex fields like metabolomics.
• Biomedical research increasingly focuses on patient-specific therapies to enhance efficacy and minimize adverse reactions.
• Molecular imaging requires agents that can visualize both structures and metabolic processes, such as cathepsin B (CtsB) activity linked to tumor metastasis.

Purpose of the Study:

• To merge molecular imaging and therapy into a single approach.
• To develop novel chemical methodologies for designing molecules with diagnostic and therapeutic capabilities.
• To utilize modified solid-phase peptide chemistry for creating highly variable conjugates.

Main Methods:

• Employed modified solid-phase peptide chemistry with temperature shifts during synthesis.
• Generated modular peptide-based conjugates incorporating functional modules.
• Prepared peptide nucleic acid (PNA) products targeting CtsB mRNA with a CtsB cleavage site for cell line distinction.
• Utilized a peptide-based BioShuttle carrier for intracellular delivery of functional modules.

Main Results:

• Successfully generated highly variable conjugates with diagnostic and therapeutic potential.
• Developed functional modules (PNA-based) capable of distinguishing cell lines based on CtsB gene expression.
• Demonstrated the utility of a peptide-based BioShuttle for delivering these modules into the cell cytoplasm.

Conclusions:

• Modified solid-phase peptide chemistry is a suitable technology for creating advanced molecular imaging and therapeutic agents.
• The developed modular conjugates show promise for targeted cancer diagnostics and therapeutics.
• Further investigation of these conjugates is warranted for their application in personalized medicine and cancer treatment.